ENTRY       D07473                      Drug
NAME        Atomoxetine (USP/INN);
            Tomoxetine
FORMULA     C17H21NO
EXACT_MASS  255.1623
MOL_WEIGHT  255.3547
CLASS       Neuropsychiatric agent
             DG03085  Selective norepinephrine reuptake inhibitor (NRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      ATC code: N06BA09
            Chemical structure group: DG00970
            Product (DG00970): D02574<JP/US>
EFFICACY    Stimulant (central), Selective noradrenaline reuptake inhibitor (NRI)
COMMENT     Fluoxetine derivative
TARGET      SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04721(6530)  Synaptic vesicle cycle
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
                N06BA Centrally acting sympathomimetics
                 N06BA09 Atomoxetine
                  D07473  Atomoxetine (USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00970  Atomoxetine
                D07473  Atomoxetine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00970  Atomoxetine
                D07473  Atomoxetine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D07473  Atomoxetine (USP/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07473
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00970  Atomoxetine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00970  Atomoxetine
DBLINKS     CAS: 83015-26-3
            PubChem: 51091800
            ChEBI: 127342
            LigandBox: D07473
            NIKKAJI: J525.770K
ATOM        19
            1   C8x C    19.3200  -16.8700
            2   C8x C    19.3200  -18.2700
            3   C8x C    20.5100  -18.9700
            4   C8x C    21.7700  -18.2700
            5   C8y C    21.7700  -16.8700
            6   C8y C    20.5100  -16.1700
            7   C1a C    20.5100  -14.7700
            8   O2a O    22.9600  -16.1700
            9   C1c C    24.2200  -16.8700
            10  C1b C    25.4100  -16.1700
            11  C1b C    26.6000  -16.8700
            12  N1b N    27.8600  -16.1700
            13  C1a C    29.0500  -16.8700
            14  C8y C    24.2200  -18.2700
            15  C8x C    23.0300  -18.9700
            16  C8x C    23.0300  -20.3700
            17  C8x C    24.2200  -21.0700
            18  C8x C    25.4100  -20.3700
            19  C8x C    25.4100  -18.9700
BOND        20
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     5   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14    9  14 1 #Down
            15   14  15 2
            16   15  16 1
            17   16  17 2
            18   17  18 1
            19   18  19 2
            20   14  19 1
///
